No Data
No Data
Engaged Capital's Q1 Moves: Adds Envestnet, Trims Shake Shack, Others
Express News | NYSE Order Imbalance 89505.0 Shares on Buy Side
Analysts Have Conflicting Sentiments on These Healthcare Companies: Praxis Precision Medicines (PRAX), Iovance Biotherapeutics (IOVA) and Evolent Health (EVH)
Express News | Evolent Health Inc : Truist Securities Cuts Target Price to $28 From $34
Truist Adjusts Evolent Health's Price Target to $28 From $34, Notes Near-Term Lack of Claims Visibility; Keeps Hold Rating
Truist Adjusts Evolent Health's Price Target to $28 From $34, Notes Near-Term Lack of Claims Visibility; Keeps Hold Rating.
Evolent Health, Inc. (NYSE:EVH) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates
Last week, you might have seen that Evolent Health, Inc. (NYSE:EVH) released its first-quarter result to the market. The early response was not positive, with shares down 9.7% to US$24.46 in the past
No Data